Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Survivin-targeting anti-tumor agents and uses thereof

Survivin-targeting anti-tumor agents and uses thereof

US Patent 12115158 · Granted Oct 15, 2024

Estimated economic value: $654,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Broadband decoupling radiating elements and base station antennas having such ra2025
Methods for synthesis of the tricyclic prostaglandin D2 metabolite methyl ester2025
Connection assembly for antenna and base station antenna2025
Tropomyosin receptor kinase (TRK) degradation compounds and methods of use2025
Pan-KIT kinase inhibitor having quinoline structure and application thereof2025
Lubricious thermoplastic compounds and thermoplastic articles made therefrom2025
MST1 kinase inhibitor and use thereof2025
Pyrazole derivatives and use thereof2025
Selective PI3Kδ inhibitor and use thereof2025
(Di)amination of activated allene compounds, derivatives thereof, and methods fo2024
Indazole kinase inhibitor and use thereof2024
Compounds and methods to sensitize cancer cells to cisplatin2024